Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies.

MLA

Senev, Aleksandar, et al. “Risk Factors, Histopathological Features, and Graft Outcome of Transplant Glomerulopathy in the Absence of Donor-Specific HLA Antibodies.” Kidney International, vol. 100, no. 2, Aug. 2021, pp. 401–14. EBSCOhost, https://doi.org/10.1016/j.kint.2021.01.029.

APA

Senev, A., Van Loon, E., Lerut, E., Callemeyn, J., Coemans, M., Van Sandt, V., Kuypers, D., Emonds, M.-P., & Naesens, M. (2021). Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies. Kidney International, 100(2), 401–414. https://doi.org/10.1016/j.kint.2021.01.029

Chicago

Senev, Aleksandar, Elisabet Van Loon, Evelyne Lerut, Jasper Callemeyn, Maarten Coemans, Vicky Van Sandt, Dirk Kuypers, Marie-Paule Emonds, and Maarten Naesens. 2021. “Risk Factors, Histopathological Features, and Graft Outcome of Transplant Glomerulopathy in the Absence of Donor-Specific HLA Antibodies.” Kidney International 100 (2): 401–14. doi:10.1016/j.kint.2021.01.029.